Canton Strategic Holdings (CNTN) Long-Term Debt Issuances (2021 - 2025)
Canton Strategic Holdings' (CNTN) quarterly Long-Term Debt Issuances came in at $68501.0 in Q4 2025, down 22.68% on a QoQ basis from $88599.0 in Q3 2025.
Analysis
Canton Strategic Holdings (CNTN) Long-Term Debt Issuances (2021 - 2025) Analysis & Trends
Canton Strategic Holdings (CNTN) has 3 years of Long-Term Debt Issuances data on file, last reported at $68501.0 in Q4 2025.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $68501.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $221869.0 (changed N/A YoY) and the FY2025 annual result came in at $221869.0, changed N/A from the prior year.
- Long-Term Debt Issuances retreated to $68501.0 in Q4 2025, from $88599.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $379989.0 in Q2 2021 to a low of -$14645.0 in Q3 2022.
- A 3-year average of $130866.3 and a median of $68501.0 in 2025 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 56.77% in 2022, down 104.37% in 2022.
- Tracing CNTN's Long-Term Debt Issuances over 3 years: stood at $40001.0 in 2021, then slumped by 63.39% to $14645.0 in 2022, then jumped by 367.74% to $68501.0 in 2025.
- The last three Long-Term Debt Issuances figures came in at $68501.0 (Q4 2025), $88599.0 (Q3 2025), and $21738.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 68,501.00 |
| Sep 30, 2025 | 88,599.00 |
| Jun 30, 2025 | 21,738.00 |
| Mar 31, 2025 | 43,031.00 |
| Mar 31, 2022 | 139,645.00 |
| Dec 31, 2021 | 40,001.00 |
| Sep 30, 2021 | 335,000.00 |
| Jun 30, 2021 | 379,989.00 |
| Mar 31, 2021 | 323,025.00 |